Zihan Cui

Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Antitumor Effects of Broadleaf Vetch Against Esophageal Squamous Cell Carcinoma Through Dual Mechanisms: Suppressing EMT and Inducing Ferroptosis with Predicted Hepatorenal Toxicity-An Integrative Network Pharmacology and Toxicology Study.

Antitumor Effects of Broadleaf Vetch Against Esophageal Squamous Cell Carcinoma Through Dual Mechanisms: Suppressing EMT and Inducing Ferroptosis with Predicted Hepatorenal Toxicity-An Integrative Network Pharmacology and Toxicology Study.

Journal: Cancers
Published: November 17, 2025

Neoadjuvant Selpercatinib for Stage IIIA Primary Pulmonary Adenocarcinoma With RET Fusion: A Case Report.

Neoadjuvant Selpercatinib for Stage IIIA Primary Pulmonary Adenocarcinoma With RET Fusion: A Case Report.

Journal: Respirology case reports
Published: September 11, 2025

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.

Journal: Frontiers in immunology
Published: October 16, 2022

Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.

Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.

Journal: Cancer
Published: April 30, 2022

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.

Journal: Cell death & disease
Published: January 10, 2022

Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways.

Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways.

Journal: Free radical biology & medicine
Published: December 11, 2021

CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.

CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.

Journal: Journal of molecular histology
Published: October 13, 2021

Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.

Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.

Journal: Translational lung cancer research
Published: July 02, 2021

Preoperative evaluation of the segmental artery by three-dimensional image reconstruction vs. thin-section multi-detector computed tomography.

Preoperative evaluation of the segmental artery by three-dimensional image reconstruction vs. thin-section multi-detector computed tomography.

Journal: Journal of thoracic disease
Published: September 18, 2020

Comparison of the results of two chest tube managements during an enhanced recovery program after video-assisted thoracoscopic lobectomy: A randomized trial.

Comparison of the results of two chest tube managements during an enhanced recovery program after video-assisted thoracoscopic lobectomy: A randomized trial.

Journal: Thoracic cancer
Published: July 09, 2019

A circular RNA hsa_circ_0079929 inhibits tumor growth in hepatocellular carcinoma.

A circular RNA hsa_circ_0079929 inhibits tumor growth in hepatocellular carcinoma.

Journal: Cancer management and research
Published: January 19, 2019

Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.

Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.

Journal: Thoracic cancer
Published: July 11, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026